Patents Represented by Attorney, Agent or Law Firm Genome Therapeutics Corporation
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Patent number: 6800744
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumonia that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: October 5, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Lynn A. Doucette-Stamm, David Bush
  • Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
    Patent number: 6747137
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Candida albicans that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from fungal infection.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: June 8, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Keith G. Weinstock, David Bush
  • Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    Patent number: 6699703
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: March 2, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Eric Houseweart
  • Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
    Patent number: 6673910
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Moracella catarrhalis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: January 6, 2004
    Assignee: Genome Therapeutics Corporation
    Inventor: Gary L. Breton
  • Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
    Patent number: 6617156
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Enterococcus faecalis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: September 9, 2003
    Inventors: Lynn A. Doucette-Stamm, David Bush
  • Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
    Patent number: 6610836
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Klebsiella pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: August 26, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Gary L. Breton, Mark Osborne
  • Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
    Patent number: 6605709
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Proteus fragilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: August 12, 2003
    Assignee: Genome Therapeutics Corporation
    Inventor: Gary L. Breton
  • Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
    Patent number: 6583275
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived Enterococcus faecium that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: June 24, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Lynn A. Doucette-Stamm, David Bush
  • Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
    Patent number: 6562958
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Acinetobacter mirabilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: May 13, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Gary Breton, David Bush